The toxicology of HMG-CoA reductase inhibitors: prediction of human risk.

@article{Macdonald2004TheTO,
  title={The toxicology of HMG-CoA reductase inhibitors: prediction of human risk.},
  author={James S Macdonald and Margaretann M Halleck},
  journal={Toxicologic pathology},
  year={2004},
  volume={32 Suppl 2},
  pages={26-41}
}
The discovery that 3-hydroxy-3-methyglutaryl coenzyme A reductase was a rate-determining step in the biosynthesis of cholesterol led to the discovery of inhibitors of this enzyme. To support the development of these agents (statins) as potential hypocholesterolemic drugs, a variety of preclinical studies were conducted in several animal species. Not unexpectedly due to the central role played by mevalonic acid and its products including cholesterol in development and maintenance of cellular… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…